Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
Clinical trial NCT05035862 · TERMINATED
Trial details
- NCT number
- NCT05035862
- Sponsor
- Emory University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-16
- Primary completion
- 2022-12-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.